Printed From BioPortfolio.com
STAT Plus: New research on cancer-killing CAR-Ts and curative gene therapies on tap at this year’s ASH meeting
04:30 EST 4 Dec 2017 | STAT
Cancer killing CAR-T therapies will once again dominate this year’s ASH meeting, but with an important difference: They're now on the market.
Original Article: STAT Plus: New research on cancer-killing CAR-Ts and curative gene therapies on tap at this year’s ASH meeting
